Kestra Private Wealth Services’s Filana Therapeutics FLNA Stock Holding History

Kestra Private Wealth Services’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-31,500	Closed	-$1.32M	–	971
2022 Q3	$1.32M	Hold	31,500	–	–	0.08%	285
2022 Q2	$886K	Hold	31,500	–	–	0.05%	366
2022 Q1	$1.17M	Buy	+31,500	New	+$1.33M	0.06%	339
2021 Q4	–	Sell	-70,000	Closed	-$4.35M	–	1021
2021 Q3	$4.35M	Buy	+70,000	New	+$5.84M	0.24%	100
2021 Q2	–	Sell	-50,200	Closed	-$2.26M	–	917
2021 Q1	$2.26M	Buy	+50,200	New	+$1.97M	0.16%	157

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCM

Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Kestra Private Wealth Services's FLNA Position: Q4 2022 in Review

Kestra Private Wealth Services sold out of Filana Therapeutics (FLNA) in Q4 2022, closing a stake of 31,500 shares — an estimated $1.32M sold.

Kestra Private Wealth Services first reported a position in FLNA in Q1 2021 and held it in 5 quarters. The position peaked at $4.35M in Q3 2021. 153 funds tracked by Wall St. Rank hold FLNA as of Q4 2022.

Kestra Private Wealth Services reported no remaining Filana Therapeutics position as of Q4 2022 after selling out during the quarter.
Kestra Private Wealth Services sold 31,500 Filana Therapeutics shares in Q4 2022, an estimated $1.32M.
Kestra Private Wealth Services first reported a position in Filana Therapeutics in Q1 2021 and held it in 5 quarters.
Kestra Private Wealth Services's Filana Therapeutics position peaked at $4.35M in Q3 2021.
153 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2022.

Based on Kestra Private Wealth Services's 13F filing for Q4 2022, filed 1 Feb 2023.